These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 5792382)

  • 1. An open trial of low doses of dapsone in the management of lepromatous leprosy.
    Karat AB; Jeevaratnam A; Rao PS
    Lepr Rev; 1969 Apr; 40(2):99-105. PubMed ID: 5792382
    [No Abstract]   [Full Text] [Related]  

  • 2. Low dose dapsone therapy in lepromatous leprosy.
    Karat AB
    Lepr Rev; 1975 Jun; 46(2 Suppl):89-92. PubMed ID: 1100970
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemotherapeutic trials in leprosy. 7. Trial of 50 mgm. DDS twice weekly in the treatment of lepromatous leprosy.
    Pearson JM; Pettit JH
    Int J Lepr Other Mycobact Dis; 1969; 37(1):40-5. PubMed ID: 4897238
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapeutic effects of adding rimactane (rifampicin) 450 milligrams daily or 1200 milligrams once monthly in a single dose to dapsone 50 milligrams daily in patients with lepromatous leprosy.
    Languillon J; Yawalkar SJ; McDougall AC
    Int J Lepr Other Mycobact Dis; 1979 Mar; 47(1):37-43. PubMed ID: 376454
    [No Abstract]   [Full Text] [Related]  

  • 5. Clofazimine therapy of lepromatous leprosy caused by dapsone-resistant mycobacterium leprae.
    Levy L; Shepard CC; Fasal P
    Am J Trop Med Hyg; 1972 May; 21(3):315-21. PubMed ID: 4554496
    [No Abstract]   [Full Text] [Related]  

  • 6. A statistical analysis of two chemotherapy trials in lepromatous leprosy. I. The response to therapy as measured by inoculation of mice.
    Am J Trop Med Hyg; 1978 Sep; 27(5):1005-14. PubMed ID: 362950
    [No Abstract]   [Full Text] [Related]  

  • 7. Superiority of the neonatally thymectomized Lewis rat (NTLR) to monitor a clinical trial in lepromatous leprosy of the two regimens of rifampin and dapsone.
    Gelber RH; Humphres RC; Fieldsteel AH
    Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):273-83. PubMed ID: 3522770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viability of Myco. leprae in the skin and bone marrow of patients with lepromatous leprosy while on dapsone or lamprene.
    Karat AB
    Lepr Rev; 1975 Jun; 46(2 Suppl):69-72. PubMed ID: 1100966
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparison of low and conventional dosages of dapsone in the treatment of lepromatous leprosy.
    Iyer CG; Balakrishnan S; Ramu G
    Lepr India; 1977 Jul; 49(3):372-86. PubMed ID: 592740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The death rate of Mycobacterium leprae during treatment of lepromatous leprosy with acedapsone (DADDS).
    Shepard CC; Levy L; Fasal P
    Am J Trop Med Hyg; 1972 Jul; 21(4):440-5. PubMed ID: 4559065
    [No Abstract]   [Full Text] [Related]  

  • 11. Prothionamide and dapsone therapy in leprosy--a clinical study.
    Kundu SK; Hazra SK; Chaudhury SK; Chatterjee B
    Indian J Lepr; 1985; 57(1):90-6. PubMed ID: 3839829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapeutic trials in leprosy. 4. Dapsone (DDS) in low dosage in the treatment of lepromatous leprosy. A demonstration pilot study.
    Pettit JH; Rees RJ
    Int J Lepr Other Mycobact Dis; 1967; 35(2):140-8. PubMed ID: 5338958
    [No Abstract]   [Full Text] [Related]  

  • 13. Second trial of low dosages of DDS in lepromatous leprosy.
    Leiker DL; Carling D
    Lepr Rev; 1969 Jan; 40(1):54-8. PubMed ID: 4888383
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of dapsone in eliminating M. leprae from the skin of lepromatous patients, a study of 609 cases.
    Koticha KK; Sane AB
    Int J Lepr Other Mycobact Dis; 1971; 39(4):829-37. PubMed ID: 4949310
    [No Abstract]   [Full Text] [Related]  

  • 15. Response to dapsone (DDS) monotherapy in leprosy patients of Gudiyatham Taluk, South India: comparison between the 1960s and the 1970s.
    Almeida JG; Christian M; Chacko CJ
    Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):378-8. PubMed ID: 6685701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blind trial of weekly doses of sulforthomidine (fanasil (Roche)) and Disulone in lepromatous leprosy. Comparison of results after thirty months of treatment.
    Languillon J
    Int J Lepr Other Mycobact Dis; 1971; 39(2):471-5. PubMed ID: 4948086
    [No Abstract]   [Full Text] [Related]  

  • 17. Dapsone-resistant Mycobacterium leprae in a patient receiving dapsone in low doses.
    Browne SG
    Int J Lepr Other Mycobact Dis; 1969; 37(3):296-301. PubMed ID: 4906048
    [No Abstract]   [Full Text] [Related]  

  • 18. Once-monthly rifampicin plus daily dapsone in initial treatment of lepromatous leprosy.
    Yawalkar SJ; McDougall AC; Languillon J; Ghosh S; Hajra SK; Opromolla DV; Tonello CJ
    Lancet; 1982 May; 1(8283):1199-202. PubMed ID: 6122970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The continuous bacteremia of lepromatous leprosy.
    Drutz DJ; Chen TS; Lu WH
    N Engl J Med; 1972 Jul; 287(4):159-64. PubMed ID: 4555967
    [No Abstract]   [Full Text] [Related]  

  • 20. Sulphone resistance in leprosy. A review of one hundred proven clinical cases.
    Pearson JM; Rees RJ; Waters MF
    Lancet; 1975 Jul; 2(7924):69-72. PubMed ID: 49662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.